BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3024603)

  • 1. Extent of axillary dissection preceding irradiation for carcinoma of the breast.
    Schwartz GF; D'Ugo DM; Rosenberg AL
    Arch Surg; 1986 Dec; 121(12):1395-8. PubMed ID: 3024603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete axillary lymph node dissection for stage I-II carcinoma of the breast.
    Danforth DN; Findlay PA; McDonald HD; Lippman ME; Reichert CM; d'Angelo T; Gorrell CR; Gerber NL; Lichter AS; Rosenberg SA
    J Clin Oncol; 1986 May; 4(5):655-62. PubMed ID: 3701387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Exploration of the extent of axillary dissection for patients with node positive primary breast cancer].
    Ouyang T; Li JF; Wang TF; Lin BY
    Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(5):298-300. PubMed ID: 15842936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axillary lymph node dissection for intraductal breast carcinoma--is it indicated?
    Silverstein MJ; Rosser RJ; Gierson ED; Waisman JR; Gamagami P; Hoffman RS; Fingerhut AG; Lewinsky BS; Colburn W; Handel N
    Cancer; 1987 May; 59(10):1819-24. PubMed ID: 3030529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axillary lymphadenectomy for intraductal carcinoma of the breast.
    Silverstein MJ; Gierson ED; Colburn WJ; Rosser RJ; Waisman JR; Gamagami P
    Surg Gynecol Obstet; 1991 Mar; 172(3):211-4. PubMed ID: 1847243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional nodal management and patterns of failure following conservative surgery and radiation therapy for stage I and II breast cancer.
    Halverson KJ; Taylor ME; Perez CA; Garcia DM; Myerson R; Philpott G; Levy J; Simpson JR; Tucker G; Rush C
    Int J Radiat Oncol Biol Phys; 1993 Jul; 26(4):593-9. PubMed ID: 8330987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radicality effect of adding an interpectoral to a subpectoral approach for dissection of level III axillary lymph nodes in breast cancer.
    Barros AC; Andrade FE; Bevilacqua JL; Barros MA; Piato JR; Santos DR; Filassi JR; Nimir CC
    Tumori; 2013; 99(4):500-4. PubMed ID: 24471202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discontinuous or "skip" metastases in breast carcinoma. Analysis of 1228 axillary dissections.
    Rosen PP; Lesser ML; Kinne DW; Beattie EJ
    Ann Surg; 1983 Mar; 197(3):276-83. PubMed ID: 6830335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Management of the axilla in breast cancer: evidences and unresolved issues].
    Fodor J; Polgár C; Péley G; Németh G
    Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incidence and predictor of lymph node metastasis for patients with T1mi breast cancer who underwent axillary dissection and breast irradiation: an institutional analysis.
    Lee JH; Suh YJ; Shim BY; Kim SH
    Jpn J Clin Oncol; 2011 Oct; 41(10):1162-7. PubMed ID: 21903706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reappraisal of internal mammary node metastases as a prognostic factor in patients with breast cancer.
    Noguchi M; Ohta N; Koyasaki N; Taniya T; Miyazaki I; Mizukami Y
    Cancer; 1991 Nov; 68(9):1918-25. PubMed ID: 1655229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for lymph node metastases in breast ductal carcinoma in situ with minimal invasive component.
    Wasserberg N; Morgenstern S; Schachter J; Fenig E; Lelcuk S; Gutman H
    Arch Surg; 2002 Nov; 137(11):1249-52. PubMed ID: 12413311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.
    Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Chen L; Hershman DL
    JAMA Oncol; 2015 Jun; 1(3):323-32. PubMed ID: 26181180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rotter's node metastases. Therapeutic and prognostic considerations in early breast carcinoma.
    Cody HS; Egeli RA; Urban JA
    Ann Surg; 1984 Mar; 199(3):266-70. PubMed ID: 6322707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up.
    Louis-Sylvestre C; Clough K; Asselain B; Vilcoq JR; Salmon RJ; Campana F; Fourquet A
    J Clin Oncol; 2004 Jan; 22(1):97-101. PubMed ID: 14701770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
    Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
    J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Axillary skip metastases in breast cancer].
    Sun JY; Ning LS
    Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):352-5. PubMed ID: 18953834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axillary lymph node dissection in pT1 breast cancer: a retrospective analysis of 315 patients and review of the literature.
    Witt A; Obwegeser R; Auerbach L; Tempfer C; Yavuz D; Kubista E
    Wien Klin Wochenschr; 2002 Jun; 114(10-11):387-90. PubMed ID: 12708092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical management of early stage invasive breast cancer: a practice guideline.
    McCready D; Holloway C; Shelley W; Down N; Robinson P; Sinclair S; Mirsky D; ;
    Can J Surg; 2005 Jun; 48(3):185-94. PubMed ID: 16013621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [10 years' experience with the concept of breast-saving therapy in the treatment of breast cancer].
    Staffen A; Stadler B; Strasser K; Schreiner W; Wolner E
    Chirurg; 1985 Jul; 56(7):436-9. PubMed ID: 2994965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.